Eric Lefkofsky prides himself as the brainchild behind the widely acclaimed Tempus-a technology firm that specializes in the provision of technology-driven precision medicine solutions. The Chicago-based company utilizes data to provide efficient individualized care to patients.
Founded in 2015, Tempus majorly focuses on finding innovative methods of treating and managing cancer. As the founder and CEO of Tempus, Lefkofsky is responsible for spearheading of efforts to get partners and source for funding critical the realization of the company’s goals. In 2018, Tempus received $80 million worth of funding from a pool of investors including New Enterprise Associates and Revolution Growth and Kinship Trust Co. among others.
Tempus resources and funds go towards the collection and utilization of clinical data to uncover alternative cancer treatment methods that ensure the best possible outcomes for patients. For Eric Lefkofsky, it is crucial for Tempus to maintain close relationships with organizations and individuals who are together with them in the run to find more effective ways of treating cancer, from drug companies to individual doctors.
Lefkofsky is a talented author having penned ‘Accelerated Disruption: Understanding the True Speed of Innovation’-a book that focuses on technology. He studied at the University of Michigan and received his Juris Doctor at the same institution’s Law School. Eric Lefkofsky has a strong social media presence using platforms like Facebook, Twitter, and LinkedIn.
Lefkofsky is also well-known for his philanthropic activities through the Eric Lefkofsky Foundation, which focuses on children. Over 50 organizations have benefitted from funds from the trust. He, together with his wife joined a campaign dubbed “The Giving Pledge” to encourage other wealthy individuals to participate more on philanthropic causes.
Eric Lefkofsky is celebrated not only as a successful entrepreneur and innovator but also as a dedicated philanthropist focused on improving and touching the lives through philanthropy and medical solutions.
Learn More: www.artnews.com/top200/liz-and-eric-lefkofsky/